caffeine has been researched along with caffeine citrate in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (11.29) | 18.7374 |
1990's | 12 (9.68) | 18.2507 |
2000's | 21 (16.94) | 29.6817 |
2010's | 44 (35.48) | 24.3611 |
2020's | 33 (26.61) | 2.80 |
Authors | Studies |
---|---|
Irani, AJ; Merchant, RH | 1 |
Camu, F; Heffron, JJ; Heytens, L | 1 |
Amato, M; Hüppi, P; Isenschmid, M | 1 |
Creighton, SM; Stanton, SL | 1 |
Heimann, G; Koch, G; Skopnik, H | 1 |
Durrell, DE; Nahata, MC; Zingarelli, J | 1 |
Flood, E | 1 |
Noerr, B | 1 |
Bucher, HU; Duc, G | 3 |
Badoual, J; Carrier, O; Moran, C; Olive, G; Pons, G; Rey, E; Richard, MO | 1 |
Bonte, JB; Debruyne, D; Lacotte, J; Laloum, D; Moulin, M; Perrin, C | 1 |
Anwar, M; Graff, M; Hegyi, T; Hiatt, M; Mojica, N; Mondestin, H; Novo, R | 1 |
Bucher, HU; Duc, G; Fallenstein, F; Mieth, D | 1 |
Koyama, EA; Spierer, DN | 1 |
Billon, B; Le Guennec, JC; Paré, C | 1 |
El-Fadaly, MA; El-Gendi, AY; Hassan, AB; Mohamed, MF | 1 |
Chatterjee, AK; Kaveeshwar, U | 1 |
Brendstrup, L; Flachs, H; Larsen, PB; Skov, L | 1 |
Aranda, JV; Davis, GM; Lopes, JM; Mullahoo, K | 1 |
Fraser, BD | 1 |
Delgado Iribarnegaray, MF; Dominguez-Gil, A; Falcão, AC; Fernández de Gatta, MM; García, MJ; Lanao, JM; Santos Buelga, D | 1 |
Artru, AA; Dager, SR; Friedman, SD; Hayes, CE; Heide, A; Layton, ME; Posse, S; Richards, TL; Strauss, W | 1 |
DeCristofaro, JD; Katz, S; Subhani, M | 1 |
Erenberg, A; Haack, DG; Hicks, GM; Leff, RD; Mosdell, KW; Wynne, BA | 1 |
Comer, AM; Figgitt, DP; Perry, CM | 1 |
Gannon, BA | 1 |
Aujard, Y; Curzi-Dascalova, L; Gaultier, C; Rajguru, M | 1 |
Chirino-Barcelo, Y; Khoo, YM; Lee, HS; Ong, D; Tan, KL | 1 |
DHALA, S; RAJ, CV | 1 |
Bell, MS; Rajani, KB | 1 |
Catland, D; Coalson, JJ; Martin, H; Siler-Khodr, TM; Thomson, MA; Winter, VT; Yoder, BA | 1 |
Bury, G; Charles, B; Charlton, M; Flenady, V; Fraser, S; Gray, PH; Hegarty, J; Henderson-Smart, D; Horton, L; Jacklin, R; Reid, S; Rogers, Y; Shearman, A; Steer, P; Walsh, A | 1 |
Coalson, J; Thomson, M; Yoder, B | 1 |
Baudon, JJ; Biran-Mucignat, V; Ducrocq, S; Gold, F; Lebas, F | 1 |
Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F | 1 |
de Barros, CM; Papoila, AL | 1 |
Dou, Y; Liu, T; Qu, N; Ren, Y; Zou, T | 1 |
Aranda, JV; Botica, ML; Natarajan, G; Thomas, R | 1 |
Craddock, D; Leff, R; Treadway, AK | 1 |
de-Melo-Neto, VL; Freire, RC; King, AL; Lopes, FL; Mezzasalma, MA; Nardi, AE; Nascimento, I; Rassi, A; Soares-Filho, GL; Valença, AM; Veras, AB; Zin, WA | 1 |
Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
Bin-Nun, A; Ionchev, A; Meadow, W; Soloveychik, V; Sriram, S | 1 |
Charles, BG; Flenady, VJ; Gray, PH; Shearman, A; Steer, PA; Townsend, SR | 1 |
Bohlin, K; Jonsson, B; Kamper, J; Lindwall, R; Verder, H | 1 |
El Ayoubi, M; Lescure, S; Lopez, E; Moriette, G | 1 |
Breitkreutz, J; Garsuch, V | 1 |
BROWNE, RC | 1 |
Charles, BG; Flenady, VJ; Gray, PH; Steer, PA | 1 |
Duman, N; Kumral, A; Ozkan, H; Tuzun, F; Yesilirmak, DC | 1 |
Canarelli, JP; Krim, G; Léké, A; Meddah, B; Moumen Chentouf, W; Mullié, C; Tir Touil Meddah, A | 1 |
Bedetta, M; Paolillo, P; Picone, S | 1 |
Brown, J; Fominaya, CE; Johnson, KK; Lakshminrusimha, S; Lampkin, SJ; Mathew, B; Turner, AM | 1 |
Breitkreutz, J; Eckert, C; Pein, M; Preis, M | 1 |
Chawla, R; Haloi, P; Kumar, M; Singh, M | 1 |
Arand, J; Engel, C; Poets, CF; Vatlach, S | 1 |
Schoen, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Yu, T | 1 |
Biglow, M; Chandra, S; Pica, T; Pinkhasov, A | 1 |
Chen, DM; Wang, RQ; Xu, JL | 1 |
Akotia, D; Durham, J; Finer, NN; Katheria, AC; Rich, W; Sauberan, JB | 1 |
Abdel-Hady, H; Mohammed, S; Nasef, N; Nour, I; Shabaan, AE; Shouman, B | 1 |
Bi, V; Durig, T; Kulkarni, VI; Kumar, PC; Lian, Z; Majumdar, S; Morott, JT; Murthy, R; Murthy, SN; Park, JB; Pimparade, MB; Pinto, E; Repka, MA; Shivakumar, HN; Vanaja, K | 1 |
Ciosek, P; del Valle, M; Gonzalez-Calabuig, A; Kirsanov, D; Legin, A; Pein, M; Wesoły, M; Wróblewski, W; Yaroshenko, I; Zabadaj, M | 1 |
Beck, J; Lehtonen, L; Leppäsalo, J; Parikka, V; Soukka, H; Zhai, Q | 1 |
Cheng, HQ; Guo, JJ; Wang, CH; Xu, FL; Zhang, YH | 1 |
Patil, H; Pimparade, MB; Polk, AN; Repka, MA; Tiwari, RV; Ye, X | 1 |
Chung, S; Chung, SH; Kim, KS; Kim, SN; Lim, G; Park, HW | 1 |
Liu, G; Tian, X; Zhao, Y | 1 |
Carnielli, VP; Fabbri, L; Ferrari, F; Kiechl-Kohlendorfer, U; Lasagna, G; Lista, G; Papagaroufalis, K; Polackova, R; Saenz, P | 1 |
Huang, JH; Wen, XH; Wu, WY; Yu, M; Zhang, XZ; Zhu, R | 1 |
Ahmed, W; Alansari, K; Davidson, BL; El Tatawy, LA; Khalafalla, H; Toaimah, FH | 1 |
Balch, AH; Korgenski, EK; Sherwin, CM; Ward, RM; Yu, T | 1 |
Ahmad, T; Aranda, JV; Beharry, KD; Bronshtein, V; Cai, CL; Lazzaro, DR; Sadeh, J; Valencia, GB | 1 |
Aurilia, C; Ausanio, G; Balestri, E; Berardi, A; Boni, L; Bottino, R; Cacace, C; Cardilli, V; Carnielli, V; Casati, A; Ciarmoli, E; Colnaghi, M; Consigli, C; Cools, F; Cota, F; D'Onofrio, D; Dallaglio, S; Dani, C; Del Vecchio, A; di Fabio, S; Ferrero, F; Fusco, F; Gambacorta, A; Garani, G; Gargano, G; Gazzolo, D; Giordano, L; Gitto, E; Giura, F; Gizzi, C; Grappone, L; Grassia, C; Grison, A; Guidotti, I; Ilardi, L; Lio, A; Lucente, M; Maffei, G; Magaldi, R; Maranella, E; Martinelli, S; Massenzi, L; Matassa, PG; Mattia, L; Meli, V; Mescoli, G; Messina, F; Messner, H; Mondello, I; Montesano, G; Mosca, F; Nigro, G; Nobile, S; Orfeo, L; Pasqua, B; Pastorino, R; Perniola, R; Petrillo, F; Pillow, J; Poggi, C; Polglase, G; Pontiggia, F; Presta, G; Quartulli, L; Re, MP; Ricci, C; Ricotti, A; Roma, E; Sandri, F; Scorrano, A; Solinas, A; Staffler, A; Stasi, I; Tagliabue, P; Tana, M; Tirone, C; Torcetta, F; Tormena, F; van Kaam, AH; Vedovato, S; Vendettuoli, V; Vento, G; Ventura, ML; Villani, P; Visentin, S; Vitaliti, M | 1 |
Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
Jawa, G; Shrestha, B | 1 |
Corwin, MJ; Darnall, RA; Dobson, NR; Eichenwald, E; Heeren, TC; Hunt, CE; James, LP; McEntire, BL; Rhein, LM | 1 |
Abdel Raouf, SM; Abdel Wahed, MA; Issa, HM; Khafagy, SM | 1 |
Aouam, K; Ben Ameur, K; Ben Fredj, N; Ben Hmida, H; Boughattas, NA; Chaabane, A; Chadli, Z; Chioukh, FZ; Monastiri, K | 1 |
deRegnier, RA | 1 |
Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J | 1 |
Choi, BM; Hwang, J; Kim, YS; Shin, JH | 1 |
Askenazi, DJ; Boohaker, LJ; Carmody, JB; Charlton, JR; Griffin, RL; Guillet, R; Harer, MW; Selewski, DT; Swanson, JR | 1 |
Apfelbaum, JL; Fong, R; Fox, AP; Khokhar, S; Wang, L; Xie, Z; Zacny, JP | 1 |
Chen, X; Cheng, R; Feng, Y; Mao, XN; Qiu, J; Zhao, L | 1 |
Chen, J; Chen, X; Jin, L | 1 |
Firman, B; Gray, PH; Molnar, A | 1 |
Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y | 1 |
Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J | 1 |
Lyu, Y; Wang, LF; Yang, ZY; Zhang, HT; Zhang, X | 1 |
Abe, K; Hayashi, K; Takeuchi, A; Tsuchiya, H; Yamamoto, N | 1 |
Dassios, T; Greenough, A; Hunt, KA; Jeyakara, J; Subba-Rao, R; Williams, EE | 1 |
Clark, RH; Greenberg, RG; Ji, D; Ku, L; Laughon, M; Smith, PB; Zimmerman, KO | 1 |
Brossier, D; Denis, M; Faucon, C; Goyer, I; Heuzé, N; Jokic, M; Porcheret, F | 1 |
Bor, M; Ilhan, O | 2 |
Atkinson, A; Datta, AN; Jost, K; Koch, G; Pfister, M; Schönfeld, N; Schulzke, SM | 1 |
Chen, P; Huang, L; Wan, L | 1 |
Ding, Y; Gan, JM; He, T; Li, W; Liao, ZC; Wang, MJ; Yue, SJ | 1 |
Di, X; Fan, J; Guo, A; Hu, X; Huang, L; Xie, H; Xue, J; Zhao, P; Zhu, Z | 1 |
Bandari, S; Dumpa, N; Durig, T; Repka, MA; Wang, H | 1 |
Grunau, RE; Synnes, A | 1 |
Cheong, JLY; Doyle, LW | 1 |
Davis, PG | 1 |
Patel, RM; Saroha, V | 1 |
Jensen, EA | 1 |
Chen, F; Cheng, R; Guo, HL; He, X; Jia, WW; Li, L; Liu, Y; Lu, KY; Ni, MM; Qiu, JC; Xu, J | 1 |
Eichenwald, EC | 1 |
Ayede, AI; Ekhaguere, OA; Ezeaka, CV | 1 |
Zupancic, JAF | 1 |
Aranda, JV; Beharry, KD | 1 |
Gueta, I; Hanna, M; Loebstein, R; Rosen, C; Strauss, T; Taran, C; Yarden-Bilavsky, H | 1 |
Cai, YJ; Chen, XW; Li, J; Li, XL; Song, YY; Zhang, Z; Zhou, W | 1 |
Chen, PY; Dong, QY; He, XR; Hu, JT; Li, W; Wang, T; Zhang, XF | 1 |
Wang, J; Wei, Y; Xin, Y; Zheng, R | 1 |
Chen, W; Feng, X; Zheng, K | 1 |
Bao, ZD; Cai, JL; Chen, XQ; Cheng, R; Dong, XP; Fang, GD; Gao, Y; Huang, L; Li, H; Li, HX; Li, HY; Li, ZG; Li, ZY; Liu, SL; Lu, KY; Pan, ZJ; Shao, J; Shu, GH; Song, L; Wang, HY; Wang, SN; Wu, W; Wu, XP; Xu, Y; Xu, Z; Xue, M; Yang, Y; Ye, L; Yin, QG; Yin, XP; Yu, MZ; Zhou, JJ; Zhou, Q | 1 |
Chen, P; Cheng, Y; Hu, J; Huang, Z; Yang, L | 1 |
Johnson, PN; Lim, SY; May, CB; Miller, JL | 1 |
Alsweiler, JM; Cavadino, A; McKinlay, CJ; McNamara, D; Oliphant, EA | 1 |
Jiang, H; Li, Y; Liu, W; Miao, Y; Wang, A; Zhang, Y; Zhao, S; Zhou, Y | 1 |
Chaves Curioni, C; da Silva Ferreira, RC; Felderheimer da Silva, AC; Mocellin, MC | 1 |
Brattström, P; Bruschettini, M; Davis, PG; Onland, W; Russo, C; Soll, R | 1 |
18 review(s) available for caffeine and caffeine citrate
Article | Year |
---|---|
Pharmacotherapy of neonatal apnea.
Topics: Apnea; Caffeine; Citrates; Doxapram; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1991 |
Caffeine citrate: a review of its use in apnoea of prematurity.
Topics: Apnea; Brain; Caffeine; Central Nervous System Stimulants; Citrates; Drug Combinations; Heart Rate; Humans; Infant, Newborn; Infant, Premature; Randomized Controlled Trials as Topic; Respiration | 2001 |
Theophylline or caffeine: which is best for apnea of prematurity?
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Theophylline; Treatment Outcome | 2000 |
Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Humans; Infant, Newborn; Positive-Pressure Respiration; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 2009 |
[Apnea of prematurity: what's new?].
Topics: Apnea; Bradycardia; Brain Damage, Chronic; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Neonatal Screening; Oxygen; Risk Factors | 2010 |
Caffeine citrate: when and for how long. A literature review.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Infant, Newborn; Infant, Premature, Diseases | 2012 |
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Drug Monitoring; Humans; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Theophylline | 2014 |
Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-Analysis.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Citrates; Enterocolitis, Necrotizing; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Very Low Birth Weight; Risk Factors; Treatment Outcome | 2015 |
Caffeine citrate - Is it a silver bullet in neonatology?
Topics: Caffeine; Central Nervous System Stimulants; Citrates; Humans; Infant, Newborn | 2017 |
Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
Topics: Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Randomized Controlled Trials as Topic | 2018 |
Neurodevelopmental outcomes after neonatal caffeine therapy.
Topics: Animals; Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Developmental Disabilities; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Neurodevelopmental Disorders | 2020 |
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2020 |
What is bronchopulmonary dysplasia and does caffeine prevent it?
Topics: Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Pregnancy; Premature Birth | 2020 |
National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Evidence-Based Medicine; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Observational Studies as Topic | 2020 |
Cost-effectiveness and pricing of caffeine.
Topics: Caffeine; Citrates; Cost Control; Cost-Benefit Analysis; Drug Costs; Humans; Infant, Newborn; Infant, Premature, Diseases; Prescription Drugs | 2020 |
Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis.
Topics: Aminophylline; Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2022 |
Caffeine and cerebral palsy: A systematic review of randomized controlled trials and cohort studies.
Topics: Caffeine; Cerebral Palsy; Child; Health Status; Humans; Infant; Infant, Newborn; Randomized Controlled Trials as Topic | 2023 |
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Child; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases | 2023 |
26 trial(s) available for caffeine and caffeine citrate
Article | Year |
---|---|
Caffeine: does it affect your bladder?
Topics: Caffeine; Citrates; Drug Combinations; Female; Humans; Urinary Bladder; Urinary Incontinence; Urodynamics | 1990 |
Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial.
Topics: Blood Gas Monitoring, Transcutaneous; Bradycardia; Caffeine; Citrates; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hypoxia; Infant, Newborn; Infant, Premature, Diseases; Male; Random Allocation; Recurrence | 1988 |
Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
Topics: Apnea; Bradycardia; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Theophylline | 1995 |
Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
Topics: Apnea; Caffeine; Citrates; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male | 2000 |
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.
Topics: Caffeine; Citrates; Double-Blind Method; Doxapram; Drug Combinations; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Respiration, Artificial; Respiratory System Agents; Time Factors; Treatment Outcome; Ventilator Weaning | 2004 |
Practices of pharmacies that compound extemporaneous formulations.
Topics: Caffeine; Chemistry, Pharmaceutical; Citrates; Community Pharmacy Services; Drug Compounding; Drug Labeling; Prospective Studies | 2007 |
A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls.
Topics: Adult; Arousal; Caffeine; Central Nervous System Stimulants; Citrates; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Panic Disorder; Personality Inventory; Phenotype; Young Adult | 2008 |
Long-term effects of caffeine therapy for apnea of prematurity.
Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Developmental Disabilities; Epilepsy; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Male; Odds Ratio; Retinopathy of Prematurity; Survival Rate | 2007 |
Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
Topics: Apnea; Biological Availability; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infant, Newborn; Infant, Premature; Male | 2008 |
Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour.
Topics: Australia; Caffeine; Central Nervous System Stimulants; Child Development; Citrates; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant; Infant Behavior; Infant Mortality; Infant, Newborn; Male; Premature Birth; Surveys and Questionnaires; Temperament | 2011 |
Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
Topics: Bronchopulmonary Dysplasia; Caffeine; Case-Control Studies; Citrates; Drug Administration Schedule; Genetic Markers; Genotype; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Polymorphism, Single Nucleotide; Prospective Studies; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptors, Adenosine A2; Sleep Apnea Syndromes; Treatment Outcome | 2012 |
A Pilot Randomized Controlled Trial of Early versus Routine Caffeine in Extremely Premature Infants.
Topics: Blood Pressure; Caffeine; Central Nervous System Stimulants; Cerebrovascular Circulation; Citrates; Double-Blind Method; Echocardiography; Female; Gestational Age; Heart Rate; Humans; Infant, Extremely Premature; Infant, Newborn; Intensive Care Units, Neonatal; Male; Oxygen; Pilot Projects | 2015 |
High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Topics: Airway Extubation; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Double-Blind Method; Egypt; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pilot Projects; Prospective Studies; Respiration, Artificial; Tachycardia | 2015 |
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Topics: Apnea; Birth Weight; Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Treatment Outcome | 2016 |
[Effect of caffeine citrate on early pulmonary function in preterm infants with apnea].
Topics: Aminophylline; Apnea; Caffeine; Citrates; Continuous Positive Airway Pressure; Female; Humans; Infant, Newborn; Infant, Premature; Lung; Male | 2016 |
Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial.
Topics: Apnea; Bronchiolitis; Caffeine; Citrates; Double-Blind Method; Female; Humans; Infant; Male | 2016 |
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
Topics: Airway Extubation; Biological Products; Caffeine; Central Nervous System Stimulants; Citrates; Continuous Positive Airway Pressure; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Infant, Premature; Intubation, Intratracheal; Male; Phospholipids; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome | 2016 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child Development; Citrates; Developmental Disabilities; Double-Blind Method; Educational Status; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Motor Disorders | 2017 |
Caffeine Accelerates Emergence from Isoflurane Anesthesia in Humans: A Randomized, Double-blind, Crossover Study.
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Citrates; Cross-Over Studies; Double-Blind Method; Humans; Isoflurane; Male; Time Factors | 2018 |
Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Topics: Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intravenous; Interleukin-6; Interleukin-8; Length of Stay; Maintenance Chemotherapy; Male; Respiration, Artificial; Time Factors | 2020 |
[Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
Topics: Apnea; Caffeine; Child; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Prospective Studies | 2019 |
Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.
Topics: Airway Extubation; Apnea; Caffeine; Citrates; Continuous Positive Airway Pressure; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male | 2020 |
[Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
Topics: Apnea; Caffeine; Citrates; Double-Blind Method; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2020 |
Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial.
Topics: Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Prospective Studies; Respiratory Distress Syndrome, Newborn; Ventilator Weaning | 2021 |
Aminophylline in combination with caffeine citrate in neurodevelopmental treatment and follow-up of high-risk preterm infants using GMs assessment.
Topics: Aminophylline; Caffeine; Cardiotonic Agents; Central Nervous System; Central Nervous System Stimulants; Child Development; Citrates; Humans; Infant; Infant, Premature; Motor Activity | 2022 |
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial.
Topics: Adult; Caffeine; Citrates; Double-Blind Method; Female; Humans; Hypoxia; Infant; Infant, Newborn; Infant, Premature; Pregnancy | 2023 |
80 other study(ies) available for caffeine and caffeine citrate
Article | Year |
---|---|
The caffeine contracture test for malignant hyperthermia: caffeine citrate, caffeine benzoate or caffeine free base?
Topics: Animals; Benzoates; Caffeine; Citrates; Disease Susceptibility; Drug Combinations; Male; Malignant Hyperthermia; Muscle Contraction; Rats; Rats, Inbred Strains | 1991 |
Percutaneous caffeine application in the treatment of neonatal apnoea.
Topics: Administration, Cutaneous; Apnea; Caffeine; Chromatography, High Pressure Liquid; Citrates; Drug Combinations; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature | 1991 |
[Effect of methylxanthines on periodic respiration and acid gastroesophageal reflux in newborn infants].
Topics: Bradycardia; Caffeine; Citrates; Drug Combinations; Drug Therapy, Combination; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Infant, Newborn; Respiration; Respiratory Distress Syndrome, Newborn; Sleep Apnea Syndromes; Theophylline | 1990 |
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
Topics: Caffeine; Citrates; Drug Combinations; Drug Stability; Humans; Infusions, Parenteral; Injections, Intravenous; Parenteral Nutrition | 1989 |
Caffeine citrate in the NICU.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 1989 |
Caffeine citrate. Pointers in practical pharmacology.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases | 1989 |
Maturation of caffeine metabolic pathways in infancy.
Topics: Acetylation; Administration, Oral; Adult; Age Factors; Apnea; Caffeine; Chromatography, High Pressure Liquid; Citrates; Drug Combinations; Female; Humans; Hydroxylation; Infant; Infant, Newborn; Infant, Premature; Male; Pierre Robin Syndrome; Time Factors; Uracil; Xanthines | 1988 |
Treatment of caffeine intoxication by exchange transfusion in a newborn.
Topics: Acute Disease; Caffeine; Citrates; Drug Combinations; Exchange Transfusion, Whole Blood; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1987 |
Effect of caffeine on pneumogram and apnoea of infancy.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Respiration; Time Factors | 1986 |
[Effectiveness of low- and high-dose caffeine on idiopathic bradycardia and hypoxemia in premature infants].
Topics: Bradycardia; Caffeine; Citrates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypoxia; Infant, Newborn; Infant, Premature, Diseases | 1985 |
Caffeine citrate: an alternative to theophylline for apnea in prematurity.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1985 |
Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
Topics: Aging; Apnea; Breast Feeding; Caffeine; Cholestasis; Citrates; Drug Combinations; Gestational Age; Half-Life; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Liver; Longitudinal Studies; Prospective Studies | 1985 |
Antimycotic activity of some alkaloidal salts.
Topics: Alkaloids; Animals; Caffeine; Citrates; Drug Combinations; Drug Evaluation, Preclinical; Female; Guinea Pigs; Male; Mitosporic Fungi; Mucorales; Quinine; Tinea; Yeasts | 1981 |
Role of caffeine citrate on plasma transaminase & glucose levels of albino rats under high altitude stress conditions.
Topics: Alanine Transaminase; Altitude; Animals; Aspartate Aminotransferases; Blood Glucose; Caffeine; Citrates; Drug Combinations; Male; Rats; Stress, Physiological | 1980 |
Role of adenosine in the hypoxic ventilatory response of the newborn piglet.
Topics: Adenosine; Animals; Animals, Newborn; Caffeine; Cerebrospinal Fluid; Citrates; Dipyridamole; Drug Combinations; Hypoxia; Oxygen; Purinergic P1 Receptor Antagonists; Respiration; Swine; Theophylline | 1994 |
Aminophylline versus caffeine citrate...
Topics: Aminophylline; Apnea; Bradycardia; Caffeine; Cardiotonic Agents; Citrates; Clinical Trials as Topic; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Placebos; Research Design | 1995 |
Pre-test and post-test error probability.
Topics: Aminophylline; Caffeine; Citrates; Data Interpretation, Statistical; Drug Combinations; Probability | 1996 |
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Topics: Caffeine; Citrates; Drug Combinations; Drug Stability; Polypropylenes; Syringes | 1997 |
Population pharmacokinetics of caffeine in premature neonates.
Topics: Caffeine; Central Nervous System Stimulants; Citrates; Drug Combinations; Female; Humans; Infant, Newborn; Infant, Premature; Male; Models, Biological; Neonatology; Risk Factors | 1997 |
Human brain metabolic response to caffeine and the effects of tolerance.
Topics: Adult; Anxiety; Arousal; Aspartic Acid; Brain; Caffeine; Citrates; Coffee; Drug Combinations; Echo-Planar Imaging; Female; Glycolysis; Humans; Lactates; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Regional Blood Flow | 1999 |
Prediction of postdischarge complications by predischarge event recordings in infants with apnea of prematurity.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Monitoring, Ambulatory; Predictive Value of Tests | 2000 |
Sleep organization is unaffected by caffeine in premature infants.
Topics: Caffeine; Cardiotocography; Citrates; Drug Combinations; Electrooculography; Humans; Infant, Newborn; Infant, Premature; Polysomnography; Sleep; Sleep Apnea Syndromes | 2002 |
Caffeine in apnoeic Asian neonates: a sparse data analysis.
Topics: Apnea; Asia; Body Weight; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Citrates; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Statistics as Topic | 2002 |
EFFECT OF NATURALLY OCCURRING XANTHINES ON BACTERIA. I. ANTIMICROBIAL ACTION AND POTENTIATING EFFECT ON ANTIBIOTIC SPECTRA.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacillus subtilis; Bacteria; Caffeine; Candida; Citrates; Corynebacterium diphtheriae; Enterobacter; Enterobacter aerogenes; Escherichia coli; Klebsiella; Mycobacterium; Pharmacology; Proteus; Pseudomonas aeruginosa; Research; Salmonella paratyphi A; Salmonella typhi; Sarcina; Shigella dysenteriae; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Streptomycin; Tetracycline; Theobromine; Theophylline; Xanthines | 1965 |
Caffeine dosage in preemies questioned.
Topics: Blood Flow Velocity; Caffeine; Cerebrovascular Circulation; Citrates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Infant, Newborn; Infant, Premature; Intestines; Writing | 2003 |
Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure.
Topics: Age Factors; Animals; Animals, Newborn; Biological Products; Biopsy; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Caffeine; Cesarean Section; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Disease Models, Animal; Drug Combinations; Feasibility Studies; Humans; Infant, Newborn; Intensive Care, Neonatal; Lung; Papio; Parenteral Nutrition, Total; Phospholipids; Pulmonary Gas Exchange; Risk Factors; Time Factors; Ventilator Weaning | 2004 |
Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study.
Topics: Animals; Animals, Newborn; Biological Products; Bronchodilator Agents; Caffeine; Citrates; Continuous Positive Airway Pressure; Disease Models, Animal; Drug Combinations; Female; Humans; Infant, Newborn; Lung; Male; Papio; Phospholipids; Pilot Projects; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Respiratory Mechanics; Treatment Outcome | 2005 |
[Caffeine citrate utilization for treatment of apnea in French neonatal units].
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; France; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Surveys and Questionnaires | 2006 |
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Topics: Ambulatory Care; Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Continuous Positive Airway Pressure; Female; Gastroesophageal Reflux; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Multivariate Analysis; Pregnancy; Pregnancy, Multiple; Retrospective Studies; Risk Factors | 2006 |
Therapeutic profile of orphan medicines.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Antineoplastic Agents; Bosentan; Caffeine; Central Nervous System Stimulants; Child; Child, Preschool; Citrates; Cross-Sectional Studies; Drug Labeling; Drug Prescriptions; Drug Utilization; Female; Humans; Immunologic Factors; Infant; Infant, Newborn; Male; Middle Aged; Orphan Drug Production; Pharmacy Service, Hospital; Portugal; Rare Diseases; Sulfonamides | 2007 |
Calibration in non-linear NIR spectroscopy using principal component artificial neural networks.
Topics: Antipyrine; Caffeine; Calibration; Citrates; Neural Networks, Computer; Principal Component Analysis; Reference Standards; Regression Analysis; Spectroscopy, Near-Infrared | 2007 |
Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
Topics: Apnea; Caffeine; Citrates; Drug Monitoring; Humans; Infant, Newborn; Infant, Premature | 2007 |
Acute hemodynamic effects of caffeine administration in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2009 |
Comparative investigations on different polymers for the preparation of fast-dissolving oral films.
Topics: Administration, Oral; Caffeine; Citrates; Drug Carriers; Methylcellulose; Mouth; Polymers; Solubility; Technology, Pharmaceutical; Time Factors | 2010 |
Amphetamine and caffeine citrate in anoxaemia.
Topics: Amphetamine; Amphetamines; Caffeine; Citrates; Hypoxia; Oxygen; Respiratory System; Respiratory Tract Diseases | 1946 |
[Establishment of the intestinal microflora and regulation of bacterial translocation after caffeine citrate treatment during postnatal period in rat].
Topics: Animals; Animals, Newborn; Bacterial Translocation; Caffeine; Central Nervous System Stimulants; Citrates; Down-Regulation; Intestines; Rats; Rats, Wistar | 2012 |
Association between caffeine citrate exposure and necrotizing enterocolitis in preterm infants.
Topics: Caffeine; Case-Control Studies; Central Nervous System Stimulants; Citrates; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Retrospective Studies | 2013 |
New protocol for αAstree electronic tongue enabling full performance qualification according to ICH Q2.
Topics: Biosensing Techniques; Caffeine; Citrates; Drug Industry; Electronics; Quinine; Taste; Technology, Pharmaceutical; Tongue | 2013 |
The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
Topics: Apnea; Bradycardia; Caffeine; Central Nervous System Stimulants; Citrates; Cleft Lip; Cleft Palate; Female; Holoprosencephaly; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Postoperative Complications | 2013 |
Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
Topics: Apnea; Caffeine; Chemistry, Pharmaceutical; Citrates; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Licensure; Longitudinal Studies; Male | 2014 |
Pretreatment With Caffeine Citrate to Increase Seizure Duration During Electroconvulsive Therapy: A Case Series.
Topics: Aged; Aged, 80 and over; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Electroconvulsive Therapy; Female; Humans; Male; Retrospective Studies; Seizures; Time Factors | 2016 |
[Comparison of caffeine citrate and aminophylline for treating primary apnea in premature infants].
Topics: Aminophylline; Apnea; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Male; Retrospective Studies | 2014 |
Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.
Topics: Caffeine; Cellulose; Chemistry, Pharmaceutical; Citrates; Drug Carriers; Drug Compounding; Humans; Plasticizers; Solubility; Tablets; Taste; Taste Perception | 2015 |
Independent comparison study of six different electronic tongues applied for pharmaceutical analysis.
Topics: Biosensing Techniques; Caffeine; Chemistry, Pharmaceutical; Citrates; Citric Acid; Electrical Equipment and Supplies; Equipment Design; Lactose; Models, Theoretical; Polysaccharides; Potentiometry; Principal Component Analysis; Reproducibility of Results; Saccharin; Technology, Pharmaceutical | 2015 |
The effect of caffeine citrate on neural breathing pattern in preterm infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Male; Respiration | 2015 |
[Effects of caffeine citrate on myelin basic protein in neonatal rats with hypoxic-ischemic brain damage].
Topics: Animals; Animals, Newborn; Caffeine; Citrates; Female; Hypoxia-Ischemia, Brain; Male; Myelin Basic Protein; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; White Matter | 2015 |
Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.
Topics: Administration, Oral; Animals; Caffeine; Chemistry, Pharmaceutical; Citrates; Electronic Nose; Excipients; Humans; Male; Pediatrics; Quality Control; Rats; Rats, Sprague-Dawley; Solutions; Taste; Technology, Pharmaceutical | 2017 |
The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Citrates; Europe; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Product Surveillance, Postmarketing | 2016 |
Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
Topics: Apnea; Caffeine; Citrates; Drug Monitoring; Female; Heart Rate; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Retrospective Studies | 2016 |
Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Arteries; Body Weight; Caffeine; Central Nervous System Stimulants; Choroid; Citrates; Dinoprost; Drug Synergism; Female; Hemorrhage; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Ketorolac; Neovascularization, Pathologic; Oxygen; Rats; Rats, Sprague-Dawley; Retina; Retinopathy of Prematurity; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2016 |
Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age.
Topics: Adult; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Citrates; Drug Administration Schedule; Female; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oximetry; Prospective Studies | 2017 |
Effect of caffeine on superior mesenteric artery blood flow velocities in preterm neonates.
Topics: Blood Flow Velocity; Caffeine; Citrates; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Male; Mesenteric Artery, Superior; Pregnancy; Premature Birth; Regional Blood Flow; Ultrasonography, Doppler, Duplex | 2019 |
Therapeutic drug monitoring of caffeine in preterm infants: Could saliva be an alternative to serum?
Topics: Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Female; Humans; Infant, Newborn; Infant, Premature; Male; Prospective Studies; Reproducibility of Results; Saliva | 2017 |
Dosing wisely: caffeine and the preterm infant.
Topics: Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases | 2017 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Weight Gain | 2017 |
Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
Topics: Administration, Intravenous; Birth Weight; Caffeine; Citrates; Ductus Arteriosus; Ductus Arteriosus, Patent; Echocardiography; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Male; Vena Cava, Superior | 2018 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Internationality; Male; Renal Agents; Retrospective Studies | 2018 |
[Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants].
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Child; Citrates; Humans; Infant; Infant, Very Low Birth Weight; Retrospective Studies | 2018 |
Early high-dose caffeine citrate for extremely preterm infants: Neonatal and neurodevelopmental outcomes.
Topics: Adult; Caffeine; Cerebral Hemorrhage; Citrates; Databases, Factual; Dose-Response Relationship, Drug; Gestational Age; Humans; Infant, Extremely Premature; Morbidity; Outcome Assessment, Health Care; Retrospective Studies; Risk Assessment | 2019 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Patent; Electronic Health Records; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Multivariate Analysis; Off-Label Use; Treatment Outcome | 2019 |
Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Caffeine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Central Nervous System Stimulants; Cisplatin; Citrates; Drug Synergism; Drug Therapy, Combination; Female; Fibrosarcoma; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Osteosarcoma; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
Electrical activity of the diaphragm following a loading dose of caffeine citrate in ventilated preterm infants.
Topics: Action Potentials; Age Factors; Airway Extubation; Caffeine; Citrates; Diaphragm; Electromyography; Humans; Infant, Newborn; Infant, Premature; Intubation, Intratracheal; London; Premature Birth; Prospective Studies; Respiration, Artificial; Treatment Outcome | 2020 |
Wide variation in caffeine discontinuation timing in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Positive-Pressure Respiration; Respiration | 2020 |
Caffeine treatment for bronchiolitis-related apnea in the pediatric intensive care unit.
Topics: Apnea; Bronchiolitis; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Citrates; Female; Hospitalization; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Length of Stay; Male; Retrospective Studies | 2020 |
Effects of Caffeine on Splanchnic Oxygenation in Preterm Infants.
Topics: Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Oxygen Saturation; Prospective Studies; Spectroscopy, Near-Infrared; Splanchnic Circulation | 2021 |
Effects of Single Loading Dose of Intravenous Caffeine on Cerebral Oxygenation in Preterm Infants.
Topics: Brain; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Male; Oxygen; Oxygen Saturation; Prospective Studies; Spectroscopy, Near-Infrared | 2021 |
Caffeine preserves quiet sleep in preterm neonates.
Topics: Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Male; Models, Biological; Sleep; Wakefulness | 2020 |
Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
Topics: Apnea; Asian People; Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Models, Biological; Nonlinear Dynamics; Retrospective Studies | 2020 |
Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques.
Topics: Caffeine; Citrates; Drug Compounding; Drug Liberation; Excipients; Hot Melt Extrusion Technology; Humans; Polymethacrylic Acids; Printing, Three-Dimensional; Tablets; Taste | 2020 |
Childhood respiratory outcomes after neonatal caffeine therapy.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Child; Citrates; Ductus Arteriosus, Patent; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Oxygen Inhalation Therapy | 2020 |
When to start and stop caffeine and why respiratory status matters.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Hypoxia; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiration, Artificial | 2020 |
Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
Topics: Apnea; Caffeine; China; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Reference Standards; Retrospective Studies | 2021 |
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
Topics: Africa South of the Sahara; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Costs and Cost Analysis; Developing Countries; Health Services Accessibility; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Pharmaceutical Preparations; World Health Organization | 2020 |
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 2020 |
Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
Topics: Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Prospective Studies | 2021 |
The timing of withdrawal from caffeine citrate in very preterm infants.
Topics: Bronchopulmonary Dysplasia; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Retrospective Studies | 2021 |
Effects of caffeine citrate on respiratory mechanics and pulmonary function during peri-extubation in premature infants with low body weight.
Topics: Airway Extubation; Body Weight; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory Mechanics | 2022 |
Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.
Topics: Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Respiration, Artificial; Retrospective Studies | 2022 |
Caffeine Citrate Protects Against Sepsis-Associated Encephalopathy and Inhibits the UCP2/NLRP3 Axis in Astrocytes.
Topics: Animals; Astrocytes; Caffeine; Citrates; Humans; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Reactive Oxygen Species; Sepsis-Associated Encephalopathy; Uncoupling Protein 2 | 2022 |
Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature | 2023 |